Cost-benefit analysis: Combo treatment costs more, saves money laterNovember 08, 2006From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective, according to a new study sponsored by the Radiation Therapy Oncology Group (RTOG 91-11). Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer, said lead author Andre A. Konski, M.D., M.B.A., M.A., a radiation oncologist and director of clinical research in Fox Chase Cancer Center's radiation oncology department. Konski presented the results today at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Philadelphia. The study examined costs for patients with Medicare insurance who had taken part in an RTOG clinical trial, #9111, for locally advanced laryngeal cancer between 1991 and 1996. That randomized phase III trial was designed to compare three treatment regimens-two combining radiation therapy and chemotherapy and one using only radiation therapy. "In overall survival rates, there was no significant difference among the three treatment arms," Konski pointed out. "However, patients receiving induction chemotherapy as well as radiation or concurrent chemo-radiation therapy had better outcomes in terms of disease-free survival, local and regional control and preservation of their larynx. "In our subsequent economic analysis," Konski explained, "these better outcomes translated into significant savings of dollars that were spent on treating patients for complications and recurrences that occurred with the less effective therapy of radiation by itself." The specific aim of the new RTOG cost-benefit analysis was to evaluate the cost-effectiveness of the combination chemotherapy and radiation treatments compared to radiation therapy alone as viewed from the payer's perspective. Of the 547 patients who took part in RTOG 9111, Medicare cost data and clinical outcomes for 47 months were available for 66 patients. Data included Medicare Part A and Part B costs from all providers-inpatient, outpatient, skilled nursing facility, home health care, hospice and physicians. The RTOG researchers calculated expected costs for the 47-month period for each arm of the trial, based on average estimates of survival probabilities and mean monthly costs for each month. Incremental cost-effectiveness ratios were calculated as savings per life year in terms of overall survival and in terms of disease-free life years. Calculations were in 1996 dollars with the standard annual discount rate of 3 percent. "Although radiation alone costs less in and of itself, the expected mean 47-month cost of that treatment was $57,357-compared to the two treatment arms that included chemotherapy," Konski said. "Concurrent chemo-radiation cost a little more $57,870, and represented an incremental increase of $697 per life year of overall survival and $2,048 per disease-free life year." "Induction chemotherapy plus radiation therapy was the most cost-effective," Konski concluded. "At a 47-month cost of $49,018, this treatment saved $7,031 per disease free and $9336 per life year of total survival.\\\ Fox Chase Cancer Center |
|||||||||||||||||||||
| Related Cancer Treatment Current Events and Cancer Treatment News Articles Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians. Discovery offers potential new pancreatic cancer treatment Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein. Canadian cardiology team clears the way for lifesaving breast cancer treatment A team of Canadian cardiologists, in collaboration with oncologists, are playing an important role in the war against breast cancer Dr. Michael McDonald told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. Sensor biochips could aid in cancer diagnosis and treatment It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Depression in older cancer patients can be effectively treated with collaborative approach Depression in older cancer patients can be effectively treated with collaborative approach in primary-care settings New data: Hospital imaging centers poised to pull back, hitting patients hardest in rural areas Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final health care reform legislation. Studying cancer in pet dogs to find new treatments for human patients A team of scientists at the National Cancer Institute (NCI) in Bethesda, USA, says that studying pet dogs with cancer could yield valuable information on how to diagnose and treat human cancers. Prediction model superior to traditional criteria in bladder treatment decision A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy. Radiation costs vary widely by delivery, U-M study finds When cancer spreads to the bone, radiation treatments can help relieve the pain caused by the tumor. But how best to deliver the radiation may vary widely from one oncologist to the next. Survivors of childhood cancer less likely to marry Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar. More Cancer Treatment Current Events and Cancer Treatment News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||